Mukanov , K.K., K.N. Mukantayev, and P. Tarlykov. “GPR161 RECEPTOR AS A NOVEL TARGET FOR ANTIBODY-BASED IMMUNOTHERAPY OF TRIPLE-NEGATIVE BREAST CANCER”. Eurasian Journal of Applied Biotechnology, no. 1 (January 10, 2018). Accessed May 4, 2024. https://biotechlink.org/index.php/journal/article/view/76.